Padua Prediction Score for VTE Risk in Thoracic Surgery Patients

Launched by AL-NAHRAIN UNIVERSITY · Dec 10, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a tool called the Padua Prediction Score (PPS) to see how well it can predict the risk of blood clots, specifically venous thromboembolism (VTE), in patients undergoing thoracic surgery. Blood clots can lead to serious complications, so understanding who is at risk is very important. The trial aims to determine if using the PPS helps doctors better identify patients who might develop these clots during their hospital stay.

To participate in this study, patients should be between the ages of 65 and 74, have had a preoperative assessment using the PPS, and plan to stay in the hospital for more than three days. They must also be able to provide consent or have a legal guardian do so. Participants will have their risk for VTE evaluated during their hospital admission and will be followed up after surgery to check for any complications related to blood clots. It's important to note that certain patients, such as those with existing blood clot issues, severe bleeding disorders, or who are pregnant, will not be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who have undergone preoperative Padua Prediction Score assessment.
• • Inpatients with a hospital stay over 3 days
• • Written informed consent obtained from patients or their legal guardians.
• • Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.
• Exclusion Criteria:
• • Preexisting LEVT or pulmonary embolism.
• • Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease).
• • receiving any anticoagulation therapy for any reason.
• • patients who did not undergo a postoperative D-dimer test.
• • Incomplete Data: missing essential clinical or laboratory data.
• • Pregnancy: pregnant women or those within six weeks postpartum.
• • Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.